Transmission of EHV-1 by Horses with EHV-1 Myeloencephalopathy: Implications for Biosecurity and Review

Clinical Techniques in Equine Practice

Volumn 5, Issue 1, 2006, Pages 60-66

  Kohn, Catherine W ^a   Reed, Stephen M ^a   Sofaly, Cheryl D ^a   Henninger, Richard W ^a,b   Saville, William J ^a,b   Allen, George P ^a,c   Premanadan, Christopher ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FINDLAY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

biosecurity; EHV 1; horse; myeloencephalopathy; transmission

Indexed keywords

EQUID HERPESVIRUS 1; EQUIDAE; EQUUS CABALLUS; HUMAN HERPESVIRUS 1;

EID: 33646095751     PISSN: 15347516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ctep.2006.01.011     Document Type: Article

References (13)

1. Allen G.P., Kydd J.H., Slater J.D., et al. Equid herpesvirus 1 and equid herpesvirus 4 infections. In: Coetzer J.A.W., and Tustin R.C. (Eds). Infectious Diseases of Livestock (vol 2, ed 2) (2004), Oxford University Press, Cape Town, South Africa 829-859
2. Crabb B.S., Macpherson C.M., Reubel G.H., et al. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 140 (1995) 245-258
3. Allen G.P. Epidemic disease caused by equine herpesvirus-1. recommendations for prevention and control. Equine Vet Educ AE 4 (2002) 177-184
4. Davis-Poynter N. Identification of a panel of variable genetic markers enabling typing of EHV-1 strains and tracing of links between outbreaks. Dorothy Havermeyer Workshop on EHV-1 (2004), Voltona, Tuscany, Italy
5. Nugent J., Mumford J.A., Birch-Machin I., et al. DNA polymerase sequence variation is a marker of virulence for equine herpesvirus type 1. Third International Veterinary Vaccine and Diagnostics Conference (2003), Ontario Veterinary College, Guelph, Canada
6. Edington N., Bridges C.G., and Huckle A. Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 17 (1985) 369-372
7. Slater J.D., Borchers K., Thackray, et al. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol 75 (1994) 2007-2016
8. Smith D.J., Iqbal J., Purewal A., et al. In vitro reactivation of latent equid herpesvirus-1 from CD5+/CD8+ leukocytes indirectly by IL-2 or chorionic gonadotrophin. J Gen Virol 79 (1998) 2997-3004
9. Wilkins P.A. Acyclovir in the treatment of EHV-1 myeloencephalopathy. Proceedings of the 22nd American College of Veterinary Internal Medicine Forum (2004) 170-172 Minneapolis, MN
10. Collins P. The spectrum of antiviral activities of acyclovir in vitro and in vivo. J Antimicrob Chemother 12 suppl B (1983) 19-27
11. Wilkins P.A., Papich M., and Sweeney R.W. Pharmacokinetics of acyclovir in adult horses. J Vet Emerg Crit Care 15 (2005) 174-178
12. Wilkins P.A., Henninger R., Reed S.M., et al. Acyclovir as treatment for EHV-1 myeloencephalopathy. AAEP Proc (2003) 394-396
13. Patel J.R., Bateman H., Williams J., et al. Derivation and characterization of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Vet Microbiol 91 (2003) 23-29